ClearBridge Large Cap Growth ESG Strategy Q4 2024 Commentary
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
Eli Lilly Stock's Correction Brings Opportunity
Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.
Silicon Laboratories (SLAB) to Release Earnings on Wednesday
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) is projected to announce its earnings results before the market opens on ...
Vaccine stocks in focus as RFK Jr. faces confirmation hearing
Leading vaccine makers are under investor scrutiny as Robert F. Kennedy Jr., a notable vaccine skeptic and President Donald Trump’s nominee to lead the Department of Health and Human Services (HHS), ...
Global Diabetic Nephropathy Market To Reach $3.3 Billion By 2031, Growing At A CAGR Of 6%
The global diabetic nephropathy market was valued at $1.9 billion in 2021, and is projected to reach $3.3 billion by 2031, growing at a CAGR of 6%.
FirstService FY2024 EPS Estimate Lifted by Stifel Canada
Analysts at Stifel Canada raised their FY2024 earnings estimates for FirstService in a research note issued to investors on ...